MENU
RHHBY
AS OF
Feb 3 closing price
Price
$56.58
Change
+$11.04 (+24.24%)
Capitalization
361.01B
78 days until earnings call
Intraday BUY SELL Signals
+Compare
RHHBY
Stock ticker: OTC
AS OF
Feb 3 closing price
Price
$56.58
Change
+$11.04 (+24.24%)
Capitalization
361.01B

RHHBY Roche Holding Ltd Forecast, Technical & Fundamental Analysis

Roche is a Swiss biopharmaceutical and diagnostic company... Show more

RHHBY
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for RHHBY with price predictions
Feb 03, 2026

RHHBY's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for RHHBY turned positive on January 14, 2026. Looking at past instances where RHHBY's MACD turned positive, the stock continued to rise in of 47 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where RHHBY advanced for three days, in of 326 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 246 cases where RHHBY Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for RHHBY moved out of overbought territory on January 28, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 36 similar instances where the indicator moved out of overbought territory. In of the 36 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

RHHBY broke above its upper Bollinger Band on January 29, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.299) is normal, around the industry mean (9.409). P/E Ratio (21.987) is within average values for comparable stocks, (24.389). Projected Growth (PEG Ratio) (0.891) is also within normal values, averaging (1.865). Dividend Yield (0.024) settles around the average of (0.025) among similar stocks. P/S Ratio (4.470) is also within normal values, averaging (3.952).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. RHHBY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 72, placing this stock slightly better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

View a ticker or compare two or three
RHHBY
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published Dividends

RHHBY paid dividends on May 03, 2024

Roche Holding Ltd RHHBY Stock Dividends
А dividend of $1.35 per share was paid with a record date of May 03, 2024, and an ex-dividend date of March 14, 2024. Read more...
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
N/A
Address
Grenzacherstrasse 124
Phone
+41 616881111
Employees
103605
Web
https://www.roche.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IOT26.41N/A
N/A
Samsara
CIVB24.56-0.06
-0.24%
Civista Bancshares
BWIN20.50-0.09
-0.44%
The Baldwin Insurance Group Inc.
CAPN10.72-0.13
-1.20%
Cayson Acquisition Corp
CNET1.08-0.03
-2.54%
ZW Data Action Technologies Inc

RHHBY and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, RHHBY has been loosely correlated with RHHVF. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if RHHBY jumps, then RHHVF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RHHBY
1D Price
Change %
RHHBY100%
-0.95%
RHHVF - RHHBY
65%
Loosely correlated
-0.53%
NVS - RHHBY
37%
Loosely correlated
-0.78%
JNJ - RHHBY
37%
Loosely correlated
+1.02%
RHHBF - RHHBY
32%
Poorly correlated
+0.27%
BMY - RHHBY
28%
Poorly correlated
+0.18%
More